Characterization of liver masses by MRI is aided by the excellent soft tissue contrast of the modality. Additionally, a variety of MRI contrast agents are now available that increase our ability to confidently make specific diagnoses.

Sample Epic Order (click image to enlarge)

Download and Print A Request

AttachmentSize
Focal Liver Lesion Order Form1.07 MB

Examples (click on images)

This right lobe liver lesion has MRI signal characteristics that are unequivocally representative of a benign lesion: focal nodular hyperplasia.

References

  1. Grazioli L, Morana G, Kirchin MA, Schneider G. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 2005; 236:166-177. PubMed link
  2. Shamsi K, De Schepper A, Degryse H, Deckers F. Focal nodular hyperplasia of the liver: radiologic findings. Abdom Imaging 1993; 18:32-38. PubMed link
  3. Gaujoux S, Goere D, Dumont F, et al. Complete radiological response of colorectal liver metastases after chemotherapy: what can we expect? Dig Surg; 28:114-120. PubMed link
  4. Muhi A, Ichikawa T, Motosugi U, et al. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging 2011; 34:326-335. PubMed link
  5. Hirashima Y, Yamada Y, Tateishi U, et al. Pharmacokinetic parameters from 3-Tesla DCE-MRI as surrogate biomarkers of antitumor effects of bevacizumab plus FOLFIRI in colorectal cancer with liver metastasis. Int J Cancer 2012; 130:2359-2365. PubMed link
  6. Sofue K, Tsurusaki M, Tokue H, Arai Y, Sugimura K. Gd-EOB-DTPA-enhanced 3.0 T MR imaging: quantitative and qualitative comparison of hepatocyte-phase images obtained 10 min and 20 min after injection for the detection of liver metastases from colorectal carcinoma. Eur Radiol 2011; 21:2336-2343. PubMed link
  7. Koh DM, Scurr E, Collins D, et al. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am J Roentgenol 2007; 188:1001-1008. PubMed link
  8. Kamaya A, Maturen KE, Tye GA, Liu YI, Parti NN, Desser TS. Hypervascular liver lesions. Semin Ultrasound CT MR 2009; 30:387-407. PubMed link
  9. Bruegel M, Rummeny EJ. Hepatic metastases: use of diffusion-weighted echo-planar imaging. Abdom Imaging 2010; 35:454-461. PubMed link
  10. Cui Y, Zhang XP, Sun YS, Tang L, Shen L. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 2008; 248:894-900. PubMed link
  11. Ba-Ssalamah A, Fakhrai N, Matzek WK, et al. Magnetic resonance imaging of liver malignancies. Top Magn Reson Imaging 2007; 18:445-455. PubMed link

Last modified Fri, 17 Aug, 2012 at 14:43